Abstract:The purpose of this study was to investigate the potential application of small-molecular-weight Cu-64-labeled bis-DOTA-hypericin in the noninvasive assessment of response to photothermal ablation therapy. Methods: Bis-DOTA-hypericin was labeled with Cu-64 with high efficiency (> 95% without purification). Nine mice bearing subcutaneous human mammary BT474 tumors were used. Five mice were injected intratumorally with semiconductor CuS nanoparticles, followed by near-infrared laser irradiation 24 h later (12 W/cm(2) for 3 min), and 4 mice were not treated (control group). All mice were intravenously injected with Cu-64-bis-DOTA-hypericin (24 h after laser treatment in treated mice). Small-animal PET images were acquired at 2, 6, and 24 h after radiotracer injection. All mice were killed immediately after the imaging session for biodistribution and histology study. In vitro cell uptake and surface plasmon resonance studies were performed to validate the small-animal PET results. Results: Cu-64-bis-DOTA-hypericin uptake was significantly higher in the treatment group than in the control group. The percentage injected dose per gram of tissue in the treated and control groups was 1.72 +/- 0.43 and 0.76 +/- 0.19, respectively (P = 0.017), at 24 h after injection. Autoradiography and histology results were consistent with selective uptake of the radiotracer in the necrotic zone of the tumor induced by photothermal ablation therapy. In vitro results showed that treated BT474 cells had a higher uptake of Cu-64-bis-DOTA-hypericin than nontreated cells. Surface plasmon resonance study showed that bis-DOTA-hypericin had higher binding affinity to phosphatidylserine and phosphatidylethanolamine than to phosphatidylcholine. Conclusion: Cu-64-bis-DOTA-hypericin has a potential to image thermal therapy-induced tumor cell damage. The affinity of Cu-64-bis-DOTA-hypericin for injured tissues may be attributed to the breakdown of the cell membrane and exposure of phosphatidylserine or phosphatidylethanolamine to the radiotracer, which binds selectively to these phospholipids.

A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy.

A new chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous µPET/CT imaging and radiotherapy

Integrin αvβ3-Targeted [ 64 Cu]CuS Nanoparticles for PET/CT Imaging and Photothermal Ablation Therapy.

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Functionalized Cu3BiS3 Nanoparticles for Dual-Modal Imaging and Targeted Photothermal/photodynamic Therapy

Simultaneous multimodal imaging and photothermal therapy via renal-clearable manganese-doped copper sulfide nanodots

Theranostic CuS Nanoparticles Targeting Folate Receptors for PET/CT Image-Guided Photothermal Ablation Therap

Theranostic probe for simultaneous in vivo photoacoustic imaging and confined photothermolysis by pulsed laser at 1064 nm in 4T1 breast cancer model.

Simple Construction of Cu2-xS:Pt Nanoparticles As Nanotheranostic Agent for Imaging-Guided Chemo-Photothermal Synergistic Therapy of Cancer.

Construction of CXCR4 Receptor-Targeted CuFeSe2 Nano Theranostic Platform and Its Application in MR/CT Dual Model Imaging and Photothermal Therapy

Near-Infrared-Light-Responsive Copper Oxide Nanoparticles As Efficient Theranostic Nanoagents for Photothermal Tumor Ablation

Theranostic Cus Nanoparticles Targeting Folate Receptors For Pet Image-Guided Photothermal Therapy

[64Cu]CuS nanoparticles as a dual PET/CT and photoacoustic imaging agent for sentinel lymph nodes mapping

Hydrophilic Cu3BiS3 Nanoparticles for Computed Tomography Imaging and Photothermal Therapy

In Situ Fabrication of Nanoprobes for 19 F Magnetic Resonance and Photoacoustic Imaging-Guided Tumor Therapy

Multifunctional Cu-Ag2S Nanoparticles with High Photothermal Conversion Efficiency for Photoacoustic Imaging-Guided Photothermal Therapy in Vivo.

Au@CuS Nanoshells for Surface-Enhanced Raman Scattering Image-Guided Tumor Photothermal Therapy with Accelerated Hepatobiliary Excretion

Small-Animal PET of Tumor Damage Induced by Photothermal Ablation with 64Cu-Bis-dota-hypericin

64Cu-labeled melanin nanoparticles for PET/CT and radionuclide therapy of tumor.

Ultra-small Iron-Gallic Acid Coordination Polymer Nanoparticles for Chelator-Free Labeling of 64cu and Multimodal Imaging-Guided Photothermal Therapy

Construction of CuS@Fe-MOF nanoplatforms for MRI-guided synergistic photothermal-chemo therapy of tumors